nodes	percent_of_prediction	percent_of_DWPC	metapath
Cilazapril—ACE—prostate cancer	0.403	1	CbGaD
Cilazapril—ABCB1—Estramustine—prostate cancer	0.0574	0.2	CbGbCtD
Cilazapril—ABCB1—Cabazitaxel—prostate cancer	0.0378	0.132	CbGbCtD
Cilazapril—ABCB1—Estrone—prostate cancer	0.037	0.129	CbGbCtD
Cilazapril—ABCB1—Ethinyl Estradiol—prostate cancer	0.033	0.115	CbGbCtD
Cilazapril—ABCB1—Conjugated Estrogens—prostate cancer	0.0242	0.0843	CbGbCtD
Cilazapril—ABCB1—Mitoxantrone—prostate cancer	0.022	0.0767	CbGbCtD
Cilazapril—ABCB1—Estradiol—prostate cancer	0.0212	0.074	CbGbCtD
Cilazapril—ABCB1—Prednisone—prostate cancer	0.0183	0.0637	CbGbCtD
Cilazapril—ABCB1—Etoposide—prostate cancer	0.0139	0.0483	CbGbCtD
Cilazapril—ABCB1—Docetaxel—prostate cancer	0.0127	0.0442	CbGbCtD
Cilazapril—ABCB1—Doxorubicin—prostate cancer	0.00946	0.033	CbGbCtD
Cilazapril—ACE—urine—prostate cancer	0.00564	0.183	CbGeAlD
Cilazapril—SLC15A1—epithelium—prostate cancer	0.00207	0.0672	CbGeAlD
Cilazapril—ACE—prostate gland—prostate cancer	0.00202	0.0656	CbGeAlD
Cilazapril—SLC15A1—renal system—prostate cancer	0.00192	0.0623	CbGeAlD
Cilazapril—SLC15A2—prostate gland—prostate cancer	0.00176	0.0572	CbGeAlD
Cilazapril—ACE—seminal vesicle—prostate cancer	0.00171	0.0555	CbGeAlD
Cilazapril—SLC15A2—seminal vesicle—prostate cancer	0.00149	0.0484	CbGeAlD
Cilazapril—ACE—epithelium—prostate cancer	0.00149	0.0482	CbGeAlD
Cilazapril—ACE—renal system—prostate cancer	0.00138	0.0447	CbGeAlD
Cilazapril—ACE—urethra—prostate cancer	0.00135	0.0439	CbGeAlD
Cilazapril—SLC15A2—renal system—prostate cancer	0.0012	0.039	CbGeAlD
Cilazapril—SLC15A2—urethra—prostate cancer	0.00118	0.0383	CbGeAlD
Cilazapril—ACE—bone marrow—prostate cancer	0.00104	0.0338	CbGeAlD
Cilazapril—ACE—testis—prostate cancer	0.000891	0.0289	CbGeAlD
Cilazapril—SLC15A2—testis—prostate cancer	0.000777	0.0252	CbGeAlD
Cilazapril—ABCB1—prostate gland—prostate cancer	0.000712	0.0231	CbGeAlD
Cilazapril—ACE—lymph node—prostate cancer	0.000646	0.0209	CbGeAlD
Cilazapril—ABCB1—seminal vesicle—prostate cancer	0.000602	0.0195	CbGeAlD
Cilazapril—SLC15A2—lymph node—prostate cancer	0.000563	0.0183	CbGeAlD
Cilazapril—Fosinopril—ACE—prostate cancer	0.000531	0.112	CrCbGaD
Cilazapril—ABCB1—epithelium—prostate cancer	0.000523	0.017	CbGeAlD
Cilazapril—ABCB1—renal system—prostate cancer	0.000485	0.0157	CbGeAlD
Cilazapril—ABCB1—urethra—prostate cancer	0.000477	0.0155	CbGeAlD
Cilazapril—Perindopril—ACE—prostate cancer	0.000433	0.0911	CrCbGaD
Cilazapril—Spirapril—ACE—prostate cancer	0.000428	0.0901	CrCbGaD
Cilazapril—Moexipril—ACE—prostate cancer	0.00041	0.0864	CrCbGaD
Cilazapril—Benazepril—MTHFR—prostate cancer	0.000407	0.0857	CrCbGaD
Cilazapril—Lisinopril—ACE—prostate cancer	0.000382	0.0803	CrCbGaD
Cilazapril—Quinapril—ACE—prostate cancer	0.000382	0.0803	CrCbGaD
Cilazapril—Ramipril—ACE—prostate cancer	0.00037	0.0778	CrCbGaD
Cilazapril—Trandolapril—ACE—prostate cancer	0.00037	0.0778	CrCbGaD
Cilazapril—ABCB1—bone marrow—prostate cancer	0.000367	0.0119	CbGeAlD
Cilazapril—Benazepril—ACE—prostate cancer	0.000332	0.0698	CrCbGaD
Cilazapril—ABCB1—testis—prostate cancer	0.000314	0.0102	CbGeAlD
Cilazapril—Enalapril—ACE—prostate cancer	0.00028	0.0589	CrCbGaD
Cilazapril—ABCB1—lymph node—prostate cancer	0.000227	0.00737	CbGeAlD
Cilazapril—Nateglinide—CYP3A5—prostate cancer	0.000207	0.0437	CrCbGaD
Cilazapril—Enalapril—CYP3A4—prostate cancer	0.000132	0.0277	CrCbGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—SLC39A1—prostate cancer	0.000106	0.00315	CbGpPWpGaD
Cilazapril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—prostate cancer	0.000104	0.00311	CbGpPWpGaD
Cilazapril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—GADD45A—prostate cancer	0.000104	0.0031	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—MME—prostate cancer	9.63e-05	0.00287	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—CYP7B1—prostate cancer	9.28e-05	0.00276	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—GRP—prostate cancer	9.22e-05	0.00275	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—SLC26A4—prostate cancer	9.05e-05	0.00269	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—SLC12A2—prostate cancer	9.05e-05	0.00269	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—CD82—prostate cancer	9e-05	0.00268	CbGpPWpGaD
Cilazapril—Nateglinide—CYP3A4—prostate cancer	8.98e-05	0.0189	CrCbGaD
Cilazapril—ACE—Metabolism of proteins—RPL10—prostate cancer	8.96e-05	0.00267	CbGpPWpGaD
Cilazapril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—prostate cancer	8.81e-05	0.00262	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—CYP7B1—prostate cancer	8.62e-05	0.00257	CbGpPWpGaD
Cilazapril—SLC15A2—SLC-mediated transmembrane transport—SLC5A5—prostate cancer	8.59e-05	0.00256	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—NCOA2—prostate cancer	8.46e-05	0.00252	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—SLC12A2—prostate cancer	8.4e-05	0.0025	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—SLC26A4—prostate cancer	8.4e-05	0.0025	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—ATF3—prostate cancer	8.04e-05	0.00239	CbGpPWpGaD
Cilazapril—SLC15A1—SLC-mediated transmembrane transport—SLC5A5—prostate cancer	7.97e-05	0.00237	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—CXCL12—prostate cancer	7.88e-05	0.00235	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—IGFBP3—prostate cancer	7.57e-05	0.00225	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—ACHE—prostate cancer	7.39e-05	0.0022	CbGpPWpGaD
Cilazapril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRB—prostate cancer	7.37e-05	0.0022	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—SLC22A3—prostate cancer	7.34e-05	0.00219	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—PRKCZ—prostate cancer	7.33e-05	0.00218	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—DAG1—prostate cancer	7.15e-05	0.00213	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—NCOA1—prostate cancer	7.13e-05	0.00212	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—RPS19—prostate cancer	7.1e-05	0.00211	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—CTSD—prostate cancer	6.99e-05	0.00208	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—THBS1—prostate cancer	6.89e-05	0.00205	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—CXCL12—prostate cancer	6.83e-05	0.00203	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—SLC22A3—prostate cancer	6.81e-05	0.00203	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—ABCG5—prostate cancer	6.77e-05	0.00202	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—CALR—prostate cancer	6.54e-05	0.00195	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—CASP9—prostate cancer	6.43e-05	0.00191	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—STMN1—prostate cancer	6.41e-05	0.00191	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—ABCG5—prostate cancer	6.29e-05	0.00187	CbGpPWpGaD
Cilazapril—Tachycardia—Capecitabine—prostate cancer	6.26e-05	0.00026	CcSEcCtD
Cilazapril—Hypoaesthesia—Epirubicin—prostate cancer	6.26e-05	0.000259	CcSEcCtD
Cilazapril—Pharyngitis—Epirubicin—prostate cancer	6.24e-05	0.000259	CcSEcCtD
Cilazapril—Skin disorder—Capecitabine—prostate cancer	6.23e-05	0.000258	CcSEcCtD
Cilazapril—Urinary tract disorder—Epirubicin—prostate cancer	6.21e-05	0.000258	CcSEcCtD
Cilazapril—Hyperhidrosis—Capecitabine—prostate cancer	6.2e-05	0.000257	CcSEcCtD
Cilazapril—Hypotension—Docetaxel—prostate cancer	6.19e-05	0.000257	CcSEcCtD
Cilazapril—Urethral disorder—Epirubicin—prostate cancer	6.16e-05	0.000256	CcSEcCtD
Cilazapril—Loss of consciousness—Prednisone—prostate cancer	6.15e-05	0.000255	CcSEcCtD
Cilazapril—Hepatobiliary disease—Doxorubicin—prostate cancer	6.13e-05	0.000254	CcSEcCtD
Cilazapril—Epistaxis—Doxorubicin—prostate cancer	6.11e-05	0.000254	CcSEcCtD
Cilazapril—Anorexia—Capecitabine—prostate cancer	6.11e-05	0.000254	CcSEcCtD
Cilazapril—Nausea—Estradiol—prostate cancer	6.11e-05	0.000253	CcSEcCtD
Cilazapril—Vomiting—Mitoxantrone—prostate cancer	6.09e-05	0.000253	CcSEcCtD
Cilazapril—Sinusitis—Doxorubicin—prostate cancer	6.08e-05	0.000252	CcSEcCtD
Cilazapril—Visual impairment—Epirubicin—prostate cancer	6.06e-05	0.000251	CcSEcCtD
Cilazapril—Agranulocytosis—Doxorubicin—prostate cancer	6.05e-05	0.000251	CcSEcCtD
Cilazapril—Hypertension—Prednisone—prostate cancer	6.04e-05	0.000251	CcSEcCtD
Cilazapril—Rash—Mitoxantrone—prostate cancer	6.04e-05	0.000251	CcSEcCtD
Cilazapril—Dermatitis—Mitoxantrone—prostate cancer	6.04e-05	0.00025	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Docetaxel—prostate cancer	6.03e-05	0.00025	CcSEcCtD
Cilazapril—Headache—Mitoxantrone—prostate cancer	6e-05	0.000249	CcSEcCtD
Cilazapril—Hypotension—Capecitabine—prostate cancer	5.99e-05	0.000249	CcSEcCtD
Cilazapril—Insomnia—Docetaxel—prostate cancer	5.99e-05	0.000248	CcSEcCtD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—SLC22A1—prostate cancer	5.98e-05	0.00178	CbGpPWpGaD
Cilazapril—Myalgia—Prednisone—prostate cancer	5.96e-05	0.000247	CcSEcCtD
Cilazapril—Arthralgia—Prednisone—prostate cancer	5.96e-05	0.000247	CcSEcCtD
Cilazapril—Paraesthesia—Docetaxel—prostate cancer	5.95e-05	0.000247	CcSEcCtD
Cilazapril—Erythema multiforme—Epirubicin—prostate cancer	5.95e-05	0.000247	CcSEcCtD
Cilazapril—Anxiety—Prednisone—prostate cancer	5.94e-05	0.000246	CcSEcCtD
Cilazapril—Bradycardia—Doxorubicin—prostate cancer	5.92e-05	0.000246	CcSEcCtD
Cilazapril—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	5.92e-05	0.000245	CcSEcCtD
Cilazapril—Dyspnoea—Docetaxel—prostate cancer	5.9e-05	0.000245	CcSEcCtD
Cilazapril—Somnolence—Docetaxel—prostate cancer	5.89e-05	0.000244	CcSEcCtD
Cilazapril—Discomfort—Prednisone—prostate cancer	5.89e-05	0.000244	CcSEcCtD
Cilazapril—Hypersensitivity—Etoposide—prostate cancer	5.87e-05	0.000244	CcSEcCtD
Cilazapril—Tinnitus—Epirubicin—prostate cancer	5.86e-05	0.000243	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Capecitabine—prostate cancer	5.84e-05	0.000242	CcSEcCtD
Cilazapril—Cardiac disorder—Epirubicin—prostate cancer	5.84e-05	0.000242	CcSEcCtD
Cilazapril—Flushing—Epirubicin—prostate cancer	5.84e-05	0.000242	CcSEcCtD
Cilazapril—Rhinitis—Doxorubicin—prostate cancer	5.83e-05	0.000242	CcSEcCtD
Cilazapril—Dyspepsia—Docetaxel—prostate cancer	5.83e-05	0.000242	CcSEcCtD
Cilazapril—Insomnia—Capecitabine—prostate cancer	5.8e-05	0.000241	CcSEcCtD
Cilazapril—Hypoaesthesia—Doxorubicin—prostate cancer	5.79e-05	0.00024	CcSEcCtD
Cilazapril—Pharyngitis—Doxorubicin—prostate cancer	5.77e-05	0.00024	CcSEcCtD
Cilazapril—Paraesthesia—Capecitabine—prostate cancer	5.76e-05	0.000239	CcSEcCtD
Cilazapril—Decreased appetite—Docetaxel—prostate cancer	5.76e-05	0.000239	CcSEcCtD
Cilazapril—Urinary tract disorder—Doxorubicin—prostate cancer	5.75e-05	0.000238	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Docetaxel—prostate cancer	5.72e-05	0.000237	CcSEcCtD
Cilazapril—Asthenia—Etoposide—prostate cancer	5.72e-05	0.000237	CcSEcCtD
Cilazapril—Dyspnoea—Capecitabine—prostate cancer	5.72e-05	0.000237	CcSEcCtD
Cilazapril—Oedema—Prednisone—prostate cancer	5.71e-05	0.000237	CcSEcCtD
Cilazapril—Fatigue—Docetaxel—prostate cancer	5.71e-05	0.000237	CcSEcCtD
Cilazapril—Angiopathy—Epirubicin—prostate cancer	5.7e-05	0.000237	CcSEcCtD
Cilazapril—Urethral disorder—Doxorubicin—prostate cancer	5.7e-05	0.000237	CcSEcCtD
Cilazapril—Nausea—Mitoxantrone—prostate cancer	5.69e-05	0.000236	CcSEcCtD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—GNG5—prostate cancer	5.69e-05	0.00169	CbGpPWpGaD
Cilazapril—Immune system disorder—Epirubicin—prostate cancer	5.68e-05	0.000236	CcSEcCtD
Cilazapril—Constipation—Docetaxel—prostate cancer	5.66e-05	0.000235	CcSEcCtD
Cilazapril—Pain—Docetaxel—prostate cancer	5.66e-05	0.000235	CcSEcCtD
Cilazapril—Dyspepsia—Capecitabine—prostate cancer	5.64e-05	0.000234	CcSEcCtD
Cilazapril—Chills—Epirubicin—prostate cancer	5.64e-05	0.000234	CcSEcCtD
Cilazapril—Pruritus—Etoposide—prostate cancer	5.64e-05	0.000234	CcSEcCtD
Cilazapril—Shock—Prednisone—prostate cancer	5.62e-05	0.000233	CcSEcCtD
Cilazapril—Arrhythmia—Epirubicin—prostate cancer	5.62e-05	0.000233	CcSEcCtD
Cilazapril—Visual impairment—Doxorubicin—prostate cancer	5.61e-05	0.000233	CcSEcCtD
Cilazapril—ACE—Metabolism of proteins—PLAUR—prostate cancer	5.6e-05	0.00167	CbGpPWpGaD
Cilazapril—Tachycardia—Prednisone—prostate cancer	5.57e-05	0.000231	CcSEcCtD
Cilazapril—Decreased appetite—Capecitabine—prostate cancer	5.57e-05	0.000231	CcSEcCtD
Cilazapril—Alopecia—Epirubicin—prostate cancer	5.56e-05	0.00023	CcSEcCtD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—SLC22A1—prostate cancer	5.55e-05	0.00165	CbGpPWpGaD
Cilazapril—Skin disorder—Prednisone—prostate cancer	5.55e-05	0.00023	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Capecitabine—prostate cancer	5.54e-05	0.00023	CcSEcCtD
Cilazapril—Fatigue—Capecitabine—prostate cancer	5.53e-05	0.000229	CcSEcCtD
Cilazapril—Hyperhidrosis—Prednisone—prostate cancer	5.52e-05	0.000229	CcSEcCtD
Cilazapril—Erythema multiforme—Doxorubicin—prostate cancer	5.5e-05	0.000228	CcSEcCtD
Cilazapril—Pain—Capecitabine—prostate cancer	5.48e-05	0.000227	CcSEcCtD
Cilazapril—Constipation—Capecitabine—prostate cancer	5.48e-05	0.000227	CcSEcCtD
Cilazapril—Feeling abnormal—Docetaxel—prostate cancer	5.46e-05	0.000226	CcSEcCtD
Cilazapril—Diarrhoea—Etoposide—prostate cancer	5.45e-05	0.000226	CcSEcCtD
Cilazapril—Anorexia—Prednisone—prostate cancer	5.44e-05	0.000226	CcSEcCtD
Cilazapril—Tinnitus—Doxorubicin—prostate cancer	5.42e-05	0.000225	CcSEcCtD
Cilazapril—Gastrointestinal pain—Docetaxel—prostate cancer	5.42e-05	0.000225	CcSEcCtD
Cilazapril—Flushing—Doxorubicin—prostate cancer	5.4e-05	0.000224	CcSEcCtD
Cilazapril—Cardiac disorder—Doxorubicin—prostate cancer	5.4e-05	0.000224	CcSEcCtD
Cilazapril—Flatulence—Epirubicin—prostate cancer	5.39e-05	0.000224	CcSEcCtD
Cilazapril—Tension—Epirubicin—prostate cancer	5.37e-05	0.000223	CcSEcCtD
Cilazapril—Dysgeusia—Epirubicin—prostate cancer	5.36e-05	0.000222	CcSEcCtD
Cilazapril—Nervousness—Epirubicin—prostate cancer	5.32e-05	0.000221	CcSEcCtD
Cilazapril—Feeling abnormal—Capecitabine—prostate cancer	5.28e-05	0.000219	CcSEcCtD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—GNG5—prostate cancer	5.28e-05	0.00157	CbGpPWpGaD
Cilazapril—Angiopathy—Doxorubicin—prostate cancer	5.28e-05	0.000219	CcSEcCtD
Cilazapril—Dizziness—Etoposide—prostate cancer	5.27e-05	0.000219	CcSEcCtD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—TERT—prostate cancer	5.26e-05	0.00157	CbGpPWpGaD
Cilazapril—Muscle spasms—Epirubicin—prostate cancer	5.26e-05	0.000218	CcSEcCtD
Cilazapril—Immune system disorder—Doxorubicin—prostate cancer	5.26e-05	0.000218	CcSEcCtD
Cilazapril—Gastrointestinal pain—Capecitabine—prostate cancer	5.24e-05	0.000217	CcSEcCtD
Cilazapril—Abdominal pain—Docetaxel—prostate cancer	5.24e-05	0.000217	CcSEcCtD
Cilazapril—Chills—Doxorubicin—prostate cancer	5.22e-05	0.000217	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Prednisone—prostate cancer	5.2e-05	0.000216	CcSEcCtD
Cilazapril—Arrhythmia—Doxorubicin—prostate cancer	5.2e-05	0.000216	CcSEcCtD
Cilazapril—ABCB1—Allograft Rejection—IL10—prostate cancer	5.17e-05	0.00154	CbGpPWpGaD
Cilazapril—Insomnia—Prednisone—prostate cancer	5.17e-05	0.000214	CcSEcCtD
Cilazapril—Alopecia—Doxorubicin—prostate cancer	5.14e-05	0.000213	CcSEcCtD
Cilazapril—Paraesthesia—Prednisone—prostate cancer	5.13e-05	0.000213	CcSEcCtD
Cilazapril—Urticaria—Capecitabine—prostate cancer	5.09e-05	0.000211	CcSEcCtD
Cilazapril—Ill-defined disorder—Epirubicin—prostate cancer	5.08e-05	0.000211	CcSEcCtD
Cilazapril—Abdominal pain—Capecitabine—prostate cancer	5.07e-05	0.00021	CcSEcCtD
Cilazapril—Vomiting—Etoposide—prostate cancer	5.07e-05	0.00021	CcSEcCtD
Cilazapril—Anaemia—Epirubicin—prostate cancer	5.06e-05	0.00021	CcSEcCtD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—HSP90AB1—prostate cancer	5.06e-05	0.00151	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—HIF1A—prostate cancer	5.03e-05	0.0015	CbGpPWpGaD
Cilazapril—Dyspepsia—Prednisone—prostate cancer	5.03e-05	0.000209	CcSEcCtD
Cilazapril—Rash—Etoposide—prostate cancer	5.02e-05	0.000208	CcSEcCtD
Cilazapril—Dermatitis—Etoposide—prostate cancer	5.02e-05	0.000208	CcSEcCtD
Cilazapril—Headache—Etoposide—prostate cancer	4.99e-05	0.000207	CcSEcCtD
Cilazapril—Flatulence—Doxorubicin—prostate cancer	4.99e-05	0.000207	CcSEcCtD
Cilazapril—Tension—Doxorubicin—prostate cancer	4.97e-05	0.000206	CcSEcCtD
Cilazapril—Decreased appetite—Prednisone—prostate cancer	4.97e-05	0.000206	CcSEcCtD
Cilazapril—Dysgeusia—Doxorubicin—prostate cancer	4.96e-05	0.000206	CcSEcCtD
Cilazapril—Malaise—Epirubicin—prostate cancer	4.94e-05	0.000205	CcSEcCtD
Cilazapril—Fatigue—Prednisone—prostate cancer	4.92e-05	0.000204	CcSEcCtD
Cilazapril—Nervousness—Doxorubicin—prostate cancer	4.92e-05	0.000204	CcSEcCtD
Cilazapril—Vertigo—Epirubicin—prostate cancer	4.92e-05	0.000204	CcSEcCtD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—LEP—prostate cancer	4.92e-05	0.00146	CbGpPWpGaD
Cilazapril—Syncope—Epirubicin—prostate cancer	4.91e-05	0.000204	CcSEcCtD
Cilazapril—Leukopenia—Epirubicin—prostate cancer	4.9e-05	0.000203	CcSEcCtD
Cilazapril—Constipation—Prednisone—prostate cancer	4.88e-05	0.000203	CcSEcCtD
Cilazapril—Hypersensitivity—Docetaxel—prostate cancer	4.88e-05	0.000202	CcSEcCtD
Cilazapril—Muscle spasms—Doxorubicin—prostate cancer	4.87e-05	0.000202	CcSEcCtD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—EIF2AK2—prostate cancer	4.86e-05	0.00145	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—PRKACB—prostate cancer	4.85e-05	0.00144	CbGpPWpGaD
Cilazapril—Palpitations—Epirubicin—prostate cancer	4.84e-05	0.000201	CcSEcCtD
Cilazapril—Loss of consciousness—Epirubicin—prostate cancer	4.81e-05	0.0002	CcSEcCtD
Cilazapril—ABCB1—Allograft Rejection—FASLG—prostate cancer	4.81e-05	0.00143	CbGpPWpGaD
Cilazapril—Cough—Epirubicin—prostate cancer	4.78e-05	0.000198	CcSEcCtD
Cilazapril—Asthenia—Docetaxel—prostate cancer	4.75e-05	0.000197	CcSEcCtD
Cilazapril—Nausea—Etoposide—prostate cancer	4.73e-05	0.000196	CcSEcCtD
Cilazapril—Hypertension—Epirubicin—prostate cancer	4.73e-05	0.000196	CcSEcCtD
Cilazapril—Hypersensitivity—Capecitabine—prostate cancer	4.72e-05	0.000196	CcSEcCtD
Cilazapril—Feeling abnormal—Prednisone—prostate cancer	4.71e-05	0.000195	CcSEcCtD
Cilazapril—Ill-defined disorder—Doxorubicin—prostate cancer	4.7e-05	0.000195	CcSEcCtD
Cilazapril—Pruritus—Docetaxel—prostate cancer	4.69e-05	0.000194	CcSEcCtD
Cilazapril—Anaemia—Doxorubicin—prostate cancer	4.68e-05	0.000194	CcSEcCtD
Cilazapril—Gastrointestinal pain—Prednisone—prostate cancer	4.67e-05	0.000194	CcSEcCtD
Cilazapril—Arthralgia—Epirubicin—prostate cancer	4.66e-05	0.000193	CcSEcCtD
Cilazapril—Chest pain—Epirubicin—prostate cancer	4.66e-05	0.000193	CcSEcCtD
Cilazapril—Myalgia—Epirubicin—prostate cancer	4.66e-05	0.000193	CcSEcCtD
Cilazapril—Anxiety—Epirubicin—prostate cancer	4.64e-05	0.000193	CcSEcCtD
Cilazapril—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	4.63e-05	0.000192	CcSEcCtD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—prostate cancer	4.61e-05	0.00137	CbGpPWpGaD
Cilazapril—Discomfort—Epirubicin—prostate cancer	4.6e-05	0.000191	CcSEcCtD
Cilazapril—Asthenia—Capecitabine—prostate cancer	4.6e-05	0.000191	CcSEcCtD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—NCOA2—prostate cancer	4.58e-05	0.00136	CbGpPWpGaD
Cilazapril—Malaise—Doxorubicin—prostate cancer	4.57e-05	0.000189	CcSEcCtD
Cilazapril—Dry mouth—Epirubicin—prostate cancer	4.56e-05	0.000189	CcSEcCtD
Cilazapril—Vertigo—Doxorubicin—prostate cancer	4.55e-05	0.000189	CcSEcCtD
Cilazapril—Syncope—Doxorubicin—prostate cancer	4.54e-05	0.000188	CcSEcCtD
Cilazapril—Urticaria—Prednisone—prostate cancer	4.54e-05	0.000188	CcSEcCtD
Cilazapril—Pruritus—Capecitabine—prostate cancer	4.54e-05	0.000188	CcSEcCtD
Cilazapril—Leukopenia—Doxorubicin—prostate cancer	4.53e-05	0.000188	CcSEcCtD
Cilazapril—Diarrhoea—Docetaxel—prostate cancer	4.53e-05	0.000188	CcSEcCtD
Cilazapril—ABCB1—Transmembrane transport of small molecules—SLC7A1—prostate cancer	4.52e-05	0.00135	CbGpPWpGaD
Cilazapril—Abdominal pain—Prednisone—prostate cancer	4.52e-05	0.000187	CcSEcCtD
Cilazapril—Confusional state—Epirubicin—prostate cancer	4.5e-05	0.000187	CcSEcCtD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—PRKACB—prostate cancer	4.5e-05	0.00134	CbGpPWpGaD
Cilazapril—Palpitations—Doxorubicin—prostate cancer	4.48e-05	0.000186	CcSEcCtD
Cilazapril—Oedema—Epirubicin—prostate cancer	4.47e-05	0.000185	CcSEcCtD
Cilazapril—Loss of consciousness—Doxorubicin—prostate cancer	4.45e-05	0.000185	CcSEcCtD
Cilazapril—Cough—Doxorubicin—prostate cancer	4.42e-05	0.000183	CcSEcCtD
Cilazapril—Shock—Epirubicin—prostate cancer	4.4e-05	0.000182	CcSEcCtD
Cilazapril—Diarrhoea—Capecitabine—prostate cancer	4.39e-05	0.000182	CcSEcCtD
Cilazapril—Dizziness—Docetaxel—prostate cancer	4.38e-05	0.000182	CcSEcCtD
Cilazapril—Thrombocytopenia—Epirubicin—prostate cancer	4.37e-05	0.000181	CcSEcCtD
Cilazapril—Hypertension—Doxorubicin—prostate cancer	4.37e-05	0.000181	CcSEcCtD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—SLC5A5—prostate cancer	4.36e-05	0.0013	CbGpPWpGaD
Cilazapril—Tachycardia—Epirubicin—prostate cancer	4.36e-05	0.000181	CcSEcCtD
Cilazapril—Skin disorder—Epirubicin—prostate cancer	4.34e-05	0.00018	CcSEcCtD
Cilazapril—Hyperhidrosis—Epirubicin—prostate cancer	4.32e-05	0.000179	CcSEcCtD
Cilazapril—Myalgia—Doxorubicin—prostate cancer	4.31e-05	0.000179	CcSEcCtD
Cilazapril—Arthralgia—Doxorubicin—prostate cancer	4.31e-05	0.000179	CcSEcCtD
Cilazapril—Chest pain—Doxorubicin—prostate cancer	4.31e-05	0.000179	CcSEcCtD
Cilazapril—Anxiety—Doxorubicin—prostate cancer	4.3e-05	0.000178	CcSEcCtD
Cilazapril—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	4.28e-05	0.000178	CcSEcCtD
Cilazapril—Discomfort—Doxorubicin—prostate cancer	4.26e-05	0.000177	CcSEcCtD
Cilazapril—Anorexia—Epirubicin—prostate cancer	4.26e-05	0.000177	CcSEcCtD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—NCOA2—prostate cancer	4.25e-05	0.00126	CbGpPWpGaD
Cilazapril—Dizziness—Capecitabine—prostate cancer	4.24e-05	0.000176	CcSEcCtD
Cilazapril—Dry mouth—Doxorubicin—prostate cancer	4.22e-05	0.000175	CcSEcCtD
Cilazapril—Vomiting—Docetaxel—prostate cancer	4.21e-05	0.000175	CcSEcCtD
Cilazapril—Hypersensitivity—Prednisone—prostate cancer	4.21e-05	0.000175	CcSEcCtD
Cilazapril—Rash—Docetaxel—prostate cancer	4.18e-05	0.000173	CcSEcCtD
Cilazapril—Hypotension—Epirubicin—prostate cancer	4.17e-05	0.000173	CcSEcCtD
Cilazapril—Dermatitis—Docetaxel—prostate cancer	4.17e-05	0.000173	CcSEcCtD
Cilazapril—Confusional state—Doxorubicin—prostate cancer	4.17e-05	0.000173	CcSEcCtD
Cilazapril—Headache—Docetaxel—prostate cancer	4.15e-05	0.000172	CcSEcCtD
Cilazapril—Oedema—Doxorubicin—prostate cancer	4.13e-05	0.000171	CcSEcCtD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—prostate cancer	4.13e-05	0.00123	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—CREBBP—prostate cancer	4.11e-05	0.00122	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—prostate cancer	4.11e-05	0.00122	CbGpPWpGaD
Cilazapril—Asthenia—Prednisone—prostate cancer	4.1e-05	0.00017	CcSEcCtD
Cilazapril—Vomiting—Capecitabine—prostate cancer	4.08e-05	0.000169	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Epirubicin—prostate cancer	4.07e-05	0.000169	CcSEcCtD
Cilazapril—Shock—Doxorubicin—prostate cancer	4.07e-05	0.000169	CcSEcCtD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—SLC5A5—prostate cancer	4.05e-05	0.00121	CbGpPWpGaD
Cilazapril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—prostate cancer	4.05e-05	0.00121	CbGpPWpGaD
Cilazapril—Thrombocytopenia—Doxorubicin—prostate cancer	4.05e-05	0.000168	CcSEcCtD
Cilazapril—Rash—Capecitabine—prostate cancer	4.04e-05	0.000168	CcSEcCtD
Cilazapril—Pruritus—Prednisone—prostate cancer	4.04e-05	0.000168	CcSEcCtD
Cilazapril—Insomnia—Epirubicin—prostate cancer	4.04e-05	0.000168	CcSEcCtD
Cilazapril—Dermatitis—Capecitabine—prostate cancer	4.04e-05	0.000168	CcSEcCtD
Cilazapril—Tachycardia—Doxorubicin—prostate cancer	4.03e-05	0.000167	CcSEcCtD
Cilazapril—Headache—Capecitabine—prostate cancer	4.02e-05	0.000167	CcSEcCtD
Cilazapril—Skin disorder—Doxorubicin—prostate cancer	4.01e-05	0.000167	CcSEcCtD
Cilazapril—Paraesthesia—Epirubicin—prostate cancer	4.01e-05	0.000166	CcSEcCtD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—ACHE—prostate cancer	4.01e-05	0.00119	CbGpPWpGaD
Cilazapril—Hyperhidrosis—Doxorubicin—prostate cancer	4e-05	0.000166	CcSEcCtD
Cilazapril—Dyspnoea—Epirubicin—prostate cancer	3.98e-05	0.000165	CcSEcCtD
Cilazapril—Somnolence—Epirubicin—prostate cancer	3.97e-05	0.000165	CcSEcCtD
Cilazapril—Anorexia—Doxorubicin—prostate cancer	3.94e-05	0.000163	CcSEcCtD
Cilazapril—Nausea—Docetaxel—prostate cancer	3.93e-05	0.000163	CcSEcCtD
Cilazapril—Dyspepsia—Epirubicin—prostate cancer	3.93e-05	0.000163	CcSEcCtD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—TGFBR1—prostate cancer	3.92e-05	0.00117	CbGpPWpGaD
Cilazapril—Diarrhoea—Prednisone—prostate cancer	3.91e-05	0.000162	CcSEcCtD
Cilazapril—Decreased appetite—Epirubicin—prostate cancer	3.88e-05	0.000161	CcSEcCtD
Cilazapril—ACE—Metabolism of proteins—LEP—prostate cancer	3.87e-05	0.00115	CbGpPWpGaD
Cilazapril—Hypotension—Doxorubicin—prostate cancer	3.86e-05	0.00016	CcSEcCtD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—prostate cancer	3.86e-05	0.00115	CbGpPWpGaD
Cilazapril—Gastrointestinal disorder—Epirubicin—prostate cancer	3.86e-05	0.00016	CcSEcCtD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—NCOA1—prostate cancer	3.86e-05	0.00115	CbGpPWpGaD
Cilazapril—Fatigue—Epirubicin—prostate cancer	3.85e-05	0.00016	CcSEcCtD
Cilazapril—Pain—Epirubicin—prostate cancer	3.82e-05	0.000158	CcSEcCtD
Cilazapril—Constipation—Epirubicin—prostate cancer	3.82e-05	0.000158	CcSEcCtD
Cilazapril—Nausea—Capecitabine—prostate cancer	3.81e-05	0.000158	CcSEcCtD
Cilazapril—Dizziness—Prednisone—prostate cancer	3.78e-05	0.000157	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Doxorubicin—prostate cancer	3.77e-05	0.000156	CcSEcCtD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—prostate cancer	3.76e-05	0.00112	CbGpPWpGaD
Cilazapril—Insomnia—Doxorubicin—prostate cancer	3.74e-05	0.000155	CcSEcCtD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—THBS1—prostate cancer	3.74e-05	0.00111	CbGpPWpGaD
Cilazapril—Paraesthesia—Doxorubicin—prostate cancer	3.71e-05	0.000154	CcSEcCtD
Cilazapril—Dyspnoea—Doxorubicin—prostate cancer	3.69e-05	0.000153	CcSEcCtD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—ANXA1—prostate cancer	3.68e-05	0.0011	CbGpPWpGaD
Cilazapril—Feeling abnormal—Epirubicin—prostate cancer	3.68e-05	0.000153	CcSEcCtD
Cilazapril—Somnolence—Doxorubicin—prostate cancer	3.67e-05	0.000152	CcSEcCtD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—RXRA—prostate cancer	3.67e-05	0.00109	CbGpPWpGaD
Cilazapril—Gastrointestinal pain—Epirubicin—prostate cancer	3.65e-05	0.000152	CcSEcCtD
Cilazapril—Dyspepsia—Doxorubicin—prostate cancer	3.64e-05	0.000151	CcSEcCtD
Cilazapril—Vomiting—Prednisone—prostate cancer	3.63e-05	0.000151	CcSEcCtD
Cilazapril—Rash—Prednisone—prostate cancer	3.6e-05	0.000149	CcSEcCtD
Cilazapril—Dermatitis—Prednisone—prostate cancer	3.6e-05	0.000149	CcSEcCtD
Cilazapril—Decreased appetite—Doxorubicin—prostate cancer	3.59e-05	0.000149	CcSEcCtD
Cilazapril—Headache—Prednisone—prostate cancer	3.58e-05	0.000148	CcSEcCtD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—NCOA1—prostate cancer	3.58e-05	0.00107	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—SLC39A1—prostate cancer	3.57e-05	0.00106	CbGpPWpGaD
Cilazapril—Gastrointestinal disorder—Doxorubicin—prostate cancer	3.57e-05	0.000148	CcSEcCtD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—prostate cancer	3.57e-05	0.00106	CbGpPWpGaD
Cilazapril—Fatigue—Doxorubicin—prostate cancer	3.56e-05	0.000148	CcSEcCtD
Cilazapril—Urticaria—Epirubicin—prostate cancer	3.55e-05	0.000147	CcSEcCtD
Cilazapril—Constipation—Doxorubicin—prostate cancer	3.53e-05	0.000147	CcSEcCtD
Cilazapril—Pain—Doxorubicin—prostate cancer	3.53e-05	0.000147	CcSEcCtD
Cilazapril—Abdominal pain—Epirubicin—prostate cancer	3.53e-05	0.000146	CcSEcCtD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—GADD45A—prostate cancer	3.51e-05	0.00104	CbGpPWpGaD
Cilazapril—Feeling abnormal—Doxorubicin—prostate cancer	3.41e-05	0.000141	CcSEcCtD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—RXRA—prostate cancer	3.4e-05	0.00101	CbGpPWpGaD
Cilazapril—Nausea—Prednisone—prostate cancer	3.39e-05	0.000141	CcSEcCtD
Cilazapril—Gastrointestinal pain—Doxorubicin—prostate cancer	3.38e-05	0.00014	CcSEcCtD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—prostate cancer	3.31e-05	0.000985	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—INS—prostate cancer	3.31e-05	0.000985	CbGpPWpGaD
Cilazapril—Hypersensitivity—Epirubicin—prostate cancer	3.29e-05	0.000137	CcSEcCtD
Cilazapril—Urticaria—Doxorubicin—prostate cancer	3.28e-05	0.000136	CcSEcCtD
Cilazapril—Abdominal pain—Doxorubicin—prostate cancer	3.27e-05	0.000136	CcSEcCtD
Cilazapril—Asthenia—Epirubicin—prostate cancer	3.21e-05	0.000133	CcSEcCtD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—prostate cancer	3.2e-05	0.000954	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—IGF1—prostate cancer	3.2e-05	0.000952	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—CASP9—prostate cancer	3.17e-05	0.000945	CbGpPWpGaD
Cilazapril—Pruritus—Epirubicin—prostate cancer	3.16e-05	0.000131	CcSEcCtD
Cilazapril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—prostate cancer	3.1e-05	0.000922	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—MMP2—prostate cancer	3.1e-05	0.000922	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—EGR1—prostate cancer	3.09e-05	0.000921	CbGpPWpGaD
Cilazapril—Diarrhoea—Epirubicin—prostate cancer	3.06e-05	0.000127	CcSEcCtD
Cilazapril—Hypersensitivity—Doxorubicin—prostate cancer	3.05e-05	0.000126	CcSEcCtD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA1—prostate cancer	3e-05	0.000894	CbGpPWpGaD
Cilazapril—Asthenia—Doxorubicin—prostate cancer	2.97e-05	0.000123	CcSEcCtD
Cilazapril—Dizziness—Epirubicin—prostate cancer	2.95e-05	0.000123	CcSEcCtD
Cilazapril—Pruritus—Doxorubicin—prostate cancer	2.92e-05	0.000121	CcSEcCtD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—AR—prostate cancer	2.92e-05	0.00087	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—CYP7B1—prostate cancer	2.91e-05	0.000868	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—prostate cancer	2.9e-05	0.000863	CbGpPWpGaD
Cilazapril—Vomiting—Epirubicin—prostate cancer	2.84e-05	0.000118	CcSEcCtD
Cilazapril—ABCB1—Transmembrane transport of small molecules—SLC26A4—prostate cancer	2.84e-05	0.000845	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—SLC12A2—prostate cancer	2.84e-05	0.000845	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—CXCL8—prostate cancer	2.83e-05	0.000842	CbGpPWpGaD
Cilazapril—Diarrhoea—Doxorubicin—prostate cancer	2.83e-05	0.000117	CcSEcCtD
Cilazapril—Rash—Epirubicin—prostate cancer	2.82e-05	0.000117	CcSEcCtD
Cilazapril—Dermatitis—Epirubicin—prostate cancer	2.81e-05	0.000117	CcSEcCtD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—PPARA—prostate cancer	2.8e-05	0.000834	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—EP300—prostate cancer	2.8e-05	0.000834	CbGpPWpGaD
Cilazapril—Headache—Epirubicin—prostate cancer	2.8e-05	0.000116	CcSEcCtD
Cilazapril—Dizziness—Doxorubicin—prostate cancer	2.73e-05	0.000113	CcSEcCtD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—prostate cancer	2.72e-05	0.000809	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—CASP3—prostate cancer	2.71e-05	0.000806	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—IL2—prostate cancer	2.7e-05	0.000805	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—prostate cancer	2.66e-05	0.000793	CbGpPWpGaD
Cilazapril—Nausea—Epirubicin—prostate cancer	2.65e-05	0.00011	CcSEcCtD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—VEGFA—prostate cancer	2.65e-05	0.00079	CbGpPWpGaD
Cilazapril—Vomiting—Doxorubicin—prostate cancer	2.63e-05	0.000109	CcSEcCtD
Cilazapril—Rash—Doxorubicin—prostate cancer	2.61e-05	0.000108	CcSEcCtD
Cilazapril—Dermatitis—Doxorubicin—prostate cancer	2.6e-05	0.000108	CcSEcCtD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—PPARA—prostate cancer	2.6e-05	0.000774	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—HAO1—prostate cancer	2.6e-05	0.000773	CbGpPWpGaD
Cilazapril—Headache—Doxorubicin—prostate cancer	2.59e-05	0.000107	CcSEcCtD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—prostate cancer	2.58e-05	0.000769	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—CXCL8—prostate cancer	2.57e-05	0.000766	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—prostate cancer	2.49e-05	0.000741	CbGpPWpGaD
Cilazapril—Nausea—Doxorubicin—prostate cancer	2.46e-05	0.000102	CcSEcCtD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—prostate cancer	2.37e-05	0.000707	CbGpPWpGaD
Cilazapril—ACE—Metabolism of proteins—CTNNB1—prostate cancer	2.37e-05	0.000707	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—SLC22A3—prostate cancer	2.3e-05	0.000686	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—VEGFA—prostate cancer	2.3e-05	0.000684	CbGpPWpGaD
Cilazapril—SLC15A2—Transmembrane transport of small molecules—CREBBP—prostate cancer	2.22e-05	0.000662	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—ABCG5—prostate cancer	2.13e-05	0.000633	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—GRHL1—prostate cancer	2.12e-05	0.000631	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—TST—prostate cancer	2.12e-05	0.000631	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CBR1—prostate cancer	2.12e-05	0.000631	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CSAD—prostate cancer	2.12e-05	0.000631	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—PSAT1—prostate cancer	2.12e-05	0.000631	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—ADI1—prostate cancer	2.12e-05	0.000631	CbGpPWpGaD
Cilazapril—ABCB1—Allograft Rejection—TGFB1—prostate cancer	2.11e-05	0.000628	CbGpPWpGaD
Cilazapril—SLC15A1—Transmembrane transport of small molecules—CREBBP—prostate cancer	2.06e-05	0.000615	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—prostate cancer	2.02e-05	0.000602	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—prostate cancer	2.01e-05	0.000597	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—UGT2B15—prostate cancer	1.97e-05	0.000586	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CKMT2—prostate cancer	1.97e-05	0.000586	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—UGT2B17—prostate cancer	1.97e-05	0.000586	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—GRHPR—prostate cancer	1.97e-05	0.000586	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—prostate cancer	1.96e-05	0.000583	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—APC—prostate cancer	1.9e-05	0.000565	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—SLC22A1—prostate cancer	1.88e-05	0.000559	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—prostate cancer	1.87e-05	0.000558	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—GSTM3—prostate cancer	1.85e-05	0.000551	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—PGAM2—prostate cancer	1.85e-05	0.000551	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—NAGLU—prostate cancer	1.85e-05	0.000551	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—RFK—prostate cancer	1.85e-05	0.000551	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—AOX1—prostate cancer	1.85e-05	0.000551	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—SULT2B1—prostate cancer	1.85e-05	0.000551	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—MBTPS1—prostate cancer	1.85e-05	0.000551	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—GNG5—prostate cancer	1.79e-05	0.000532	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—prostate cancer	1.76e-05	0.000523	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CYP3A43—prostate cancer	1.75e-05	0.000522	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—AMACR—prostate cancer	1.75e-05	0.000522	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—SRD5A2—prostate cancer	1.75e-05	0.000522	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—DEGS1—prostate cancer	1.75e-05	0.000522	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—NAT1—prostate cancer	1.75e-05	0.000522	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—prostate cancer	1.74e-05	0.000517	CbGpPWpGaD
Cilazapril—ABCB1—HIF-1-alpha transcription factor network—AKT1—prostate cancer	1.69e-05	0.000504	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—prostate cancer	1.68e-05	0.0005	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—HSD17B1—prostate cancer	1.67e-05	0.000498	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—prostate cancer	1.6e-05	0.000475	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—PRKACB—prostate cancer	1.52e-05	0.000453	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—prostate cancer	1.52e-05	0.000451	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—prostate cancer	1.49e-05	0.000445	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—HPGD—prostate cancer	1.49e-05	0.000444	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—B4GALT4—prostate cancer	1.49e-05	0.000444	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—prostate cancer	1.47e-05	0.000438	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—prostate cancer	1.44e-05	0.000429	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—NCOA2—prostate cancer	1.44e-05	0.000427	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—TNFRSF21—prostate cancer	1.4e-05	0.000418	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—SLC5A5—prostate cancer	1.37e-05	0.000408	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CYP7B1—prostate cancer	1.36e-05	0.000406	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—MTAP—prostate cancer	1.36e-05	0.000406	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—prostate cancer	1.36e-05	0.000406	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—prostate cancer	1.34e-05	0.000398	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—SULT1E1—prostate cancer	1.33e-05	0.000396	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—SRD5A1—prostate cancer	1.33e-05	0.000396	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—prostate cancer	1.3e-05	0.000387	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—prostate cancer	1.29e-05	0.000384	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—ACSL4—prostate cancer	1.27e-05	0.000378	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—HSD17B3—prostate cancer	1.27e-05	0.000378	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—prostate cancer	1.26e-05	0.000375	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—prostate cancer	1.26e-05	0.000374	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—ARG2—prostate cancer	1.22e-05	0.000362	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—UMPS—prostate cancer	1.22e-05	0.000362	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—PHGDH—prostate cancer	1.22e-05	0.000362	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—NCOA1—prostate cancer	1.21e-05	0.00036	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—prostate cancer	1.2e-05	0.000356	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—LDHB—prostate cancer	1.19e-05	0.000355	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CYP3A5—prostate cancer	1.17e-05	0.000349	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—prostate cancer	1.16e-05	0.000347	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—RXRA—prostate cancer	1.15e-05	0.000343	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—prostate cancer	1.13e-05	0.000338	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—PDHA1—prostate cancer	1.13e-05	0.000337	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—TCN2—prostate cancer	1.13e-05	0.000337	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—UCP3—prostate cancer	1.13e-05	0.000337	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—GSTA3—prostate cancer	1.13e-05	0.000337	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—HSD3B1—prostate cancer	1.08e-05	0.000321	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—SLC22A3—prostate cancer	1.08e-05	0.000321	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—prostate cancer	1.04e-05	0.000311	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—prostate cancer	1.04e-05	0.00031	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—TBXAS1—prostate cancer	1.03e-05	0.000308	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—GSTA4—prostate cancer	1.03e-05	0.000308	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—prostate cancer	1.02e-05	0.000304	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—GSTA2—prostate cancer	1.01e-05	0.0003	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—SULT1A1—prostate cancer	9.95e-06	0.000296	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—ABCG5—prostate cancer	9.95e-06	0.000296	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—GSTA1—prostate cancer	9.72e-06	0.00029	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—prostate cancer	9.64e-06	0.000287	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—NAT2—prostate cancer	9.61e-06	0.000286	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—HSD3B2—prostate cancer	9.61e-06	0.000286	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—GSTO1—prostate cancer	9.61e-06	0.000286	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—PLCB2—prostate cancer	9.22e-06	0.000274	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CYP2C18—prostate cancer	9.22e-06	0.000274	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—LRP2—prostate cancer	9.22e-06	0.000274	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—P4HB—prostate cancer	9.04e-06	0.000269	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—prostate cancer	8.86e-06	0.000264	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—SLC22A1—prostate cancer	8.79e-06	0.000262	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—PPARA—prostate cancer	8.79e-06	0.000262	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—SULT2A1—prostate cancer	8.57e-06	0.000255	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—prostate cancer	8.57e-06	0.000255	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—MED12—prostate cancer	8.43e-06	0.000251	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—GNG5—prostate cancer	8.36e-06	0.000249	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—NCOA3—prostate cancer	8.06e-06	0.00024	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—HPGDS—prostate cancer	7.69e-06	0.000229	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CYP2C19—prostate cancer	7.64e-06	0.000227	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—GSTT1—prostate cancer	7.45e-06	0.000222	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—ACHE—prostate cancer	7.45e-06	0.000222	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CYP2A6—prostate cancer	7.37e-06	0.000219	CbGpPWpGaD
Cilazapril—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	7.23e-06	0.000215	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—AKR1C3—prostate cancer	7.17e-06	0.000213	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—PRKACB—prostate cancer	7.13e-06	0.000212	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CYP17A1—prostate cancer	7.06e-06	0.00021	CbGpPWpGaD
Cilazapril—ABCB1—Transmembrane transport of small molecules—CREBBP—prostate cancer	6.98e-06	0.000208	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—NCOA2—prostate cancer	6.72e-06	0.0002	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—SLC5A5—prostate cancer	6.41e-06	0.000191	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CYP2E1—prostate cancer	6.26e-06	0.000187	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—NQO1—prostate cancer	6.19e-06	0.000184	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—TH—prostate cancer	6.11e-06	0.000182	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CYP3A4—prostate cancer	6.04e-06	0.00018	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CYP1B1—prostate cancer	5.94e-06	0.000177	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—GGT1—prostate cancer	5.75e-06	0.000171	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—NCOA1—prostate cancer	5.67e-06	0.000169	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CYP19A1—prostate cancer	5.58e-06	0.000166	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—RXRA—prostate cancer	5.39e-06	0.00016	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—COMT—prostate cancer	5.19e-06	0.000155	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—GSTP1—prostate cancer	5.17e-06	0.000154	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—ITPR1—prostate cancer	5.08e-06	0.000151	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—TYMS—prostate cancer	4.8e-06	0.000143	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—GSTM1—prostate cancer	4.75e-06	0.000141	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—LPL—prostate cancer	4.66e-06	0.000139	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CYP1A1—prostate cancer	4.5e-06	0.000134	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—ERCC2—prostate cancer	4.46e-06	0.000133	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—MTHFR—prostate cancer	4.2e-06	0.000125	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—PPARA—prostate cancer	4.12e-06	0.000123	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CAV1—prostate cancer	3.87e-06	0.000115	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—PIK3CG—prostate cancer	3.53e-06	0.000105	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—INS—prostate cancer	3.34e-06	9.94e-05	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—CREBBP—prostate cancer	3.27e-06	9.73e-05	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—PIK3CD—prostate cancer	3.1e-06	9.23e-05	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—NOS3—prostate cancer	2.93e-06	8.72e-05	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—PIK3CB—prostate cancer	2.7e-06	8.04e-05	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—PTGS2—prostate cancer	2.68e-06	7.97e-05	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—PTEN—prostate cancer	2.33e-06	6.95e-05	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—EP300—prostate cancer	2.23e-06	6.63e-05	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—PIK3CA—prostate cancer	1.65e-06	4.9e-05	CbGpPWpGaD
Cilazapril—ABCB1—Metabolism—AKT1—prostate cancer	1.35e-06	4.01e-05	CbGpPWpGaD
